Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems by Paola Maria Cutroneo, Daniele Sartori, Marco Tuccori, Salvatore Crisafulli, Vera Battini, Carla Carnovale, Concetta Rafaniello, Annalisa Capuano, Elisabetta Poluzzi, Ugo Moretti, Emanuel Raschi

Subjects: Get full text

A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS) by Ning Wang, Haijun Wang, Ying Chen, Yanfeng Wang

Subjects: Get full text

A disproportionality analysis of FDA adverse event reporting system events for misoprostol by Li Yang, Wenting Xu

Subjects: Get full text

Safety Evaluation of the Combination with Dexrazoxane and Anthracyclines: A Disproportionality Analysis Based on the Food and Drug Administration Adverse Event Reporting System Dat... by Danyi Liu, Junting Liu, Rui Xiao, Anqi Deng, Wei Liu

Subjects: Get full text

A real-world Pharmacovigilance study of brodalumab based on the FDA adverse event reporting system by Ke He, Kaidi Zhao, Tingyi Yin, Meng Liu, Jiashu Liu, Wenqian Du, Xinyi Liu, Baochen Cheng, Dewu Zhang, Yan Zheng

Subjects: Get full text

Assessing real-world safety of plecanatide: a pharmacovigilance study based on the FDA adverse event reporting system by Zhiyuan Zhang, Zhiyuan Zhang, Yifan Yao, Li Zhu, Li Zhu

Subjects: Get full text

Comprehensive safety evaluation of isatuximab in multiple myeloma using disproportionality analysis of FAERS and meta-analysis of randomized controlled trials by Muhammed Favas Karimbanathottathil, Beema T Yoosuf, M Mamatha, Dipika Bansal

Subjects: Get full text

Drug-induced hearing disorders: a disproportionality analysis of the FAERS database by Baojian Li, Xiaoling Hu, Zichen Yue

Subjects: Get full text

Real world pharmacovigilance assessment of drug related macular degeneration risks by Xiaodong Chen, Shinan Wu, Shaopan Wang, Chaofeng Yu, Zihan Guo, Shiya Huang, Peixin Cai, Yanliang Miao, Shiying Li, Qian Chen

Subjects: Get full text

Influence of differential source patterns in the detection of signals of disproportionate reporting for PARP inhibitors by Jordi Mestres, Jordi Mestres

Subjects: “…disproportionality analyses…”
Get full text

A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases by Qian Liu, Zhiwei Cui, Chao Deng, Chao Yang, Tao Shi

Subjects: Get full text

Drug-induced coagulopathies: a real-world pharmacovigilance study using the FDA adverse event reporting system by Yanjun Lu, Qian Xu, Shita Zhu

Subjects: Get full text

Hematological toxicities in PARP inhibitors: A real‐world study using FDA adverse event reporting system (FAERS) database by Yamin Shu, Yufeng Ding, Xucheng He, Yanxin Liu, Pan Wu, Qilin Zhang

Subjects: Get full text

Real-world pharmacovigilance of ofatumumab in multiple sclerosis: a comprehensive FAERS data analysis by Hui Chen

Subjects: Get full text

A pharmacovigilance study of the association between proton pump inhibitors and tumor adverse events based on the FDA adverse event reporting system database by Ya-Jun Zhang, Dan-Dan Duan, Qian-Yu Tian, Cai-E. Wang, Shu-Xun Wei

Subjects: Get full text

A study on the pharmacovigilance of various SGLT-2 inhibitors by Yanwen Dong, Yangyang Wang, Yangyang Wang, Xiaomei Lan, Xiaomei Lan, Huiyan Zeng, Huiyan Zeng

Subjects: Get full text

A real-world pharmacovigilance study of neuroleptic malignant syndrome based on FDA adverse event reporting system by Yu Zhang, Wei Deng, Minjian Wang, Siying Luo, Song Li

Subjects: Get full text

Real-world pharmacovigilance study of drug-induced autoimmune hepatitis from the FAERS database by Bu-kun Zhu, Si-ying Chen, Xiang Li, Shu-yun Huang, Zhan-yang Luo, Wei Zhang

Subjects: Get full text

A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databases by Siyu Lou, Zhiwei Cui, Yingyong Ou, Junyou Chen, Linmei Zhou, Ruizhen Zhao, Chengyu Zhu, Li Wang, Zhu Wu, Fan Zou

Subjects: Get full text

The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guideline by Michele Fusaroli, Francesco Salvo, Francesco Salvo, Charles Khouri, Charles Khouri, Emanuel Raschi

Subjects: “…disproportionality analysis…”
Get full text